What is the ticker symbol for Alpine Immune Sciences?

Alpine Immune Sciences trades under the ticker ALPN on NASDAQ.

What sector does Alpine Immune Sciences operate in?

Alpine Immune Sciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ALPN in a portfolio?

PortView shows ALPN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Alpine Immune Sciences (ALPN) Stock Analysis

NASDAQHealthcareBiotechnology

$64.97+0.02%

1-year price historyRange $8.54 – $64.97

52-week range$64.97

$8.33$65.00

What Alpine Immune Sciences does

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.

Key metrics

Market cap

$4.46B

P/E (TTM)

-101.52

EPS (TTM)

$-0.64

Beta

0.97

Dividend yield

0.00%

Revenue / share

$1.18

50-day avg

$52.49

200-day avg

$26.27

52-week high

$65.00

52-week low

$8.33

CEO

Mitchell H. Gold

ETFs linked to ALPN

Broad-market and Healthcare sector ETFs an investor holding Alpine Immune Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALPN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALPN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Alpine Immune Sciences?: Alpine Immune Sciences trades under the ticker ALPN on NASDAQ.
Which exchange is ALPN listed on?: ALPN is listed on NASDAQ.
What sector does Alpine Immune Sciences operate in?: Alpine Immune Sciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALPN in a portfolio?: PortView shows ALPN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.